Sort   by:  
 Page size 
UnknownCost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
Not available
S-EPMC10673815 | biostudies-literature
UnknownBiallelic ADAM22 pathogenic variants cause progressive encephalopathy and infantile-onset refractory epilepsy.
Not available
S-EPMC9337806 | biostudies-literature
UnknownSafety and effectiveness of abatacept in juvenile idiopathic arthritis: results from the PRINTO/PRCSG registry.
Not available
S-EPMC11381685 | biostudies-literature
UnknownOpportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee.
Not available
S-EPMC7136994 | biostudies-literature
UnknownAssessment of Symptom, Disability, and Financial Trajectories in Patients Hospitalized for COVID-19 at 6 Months.
Not available
S-EPMC9929698 | biostudies-literature
Sort   by:  
 Page size